<?xml version="1.0" encoding="UTF-8"?>
<p id="par0200">Ribavirin is an antiviral compound. It works as a guanosine analogue and usually in combination with IFN (α, β). Preclinical studies with Ribavirin have shown promise, but clinical data in the treatment of MERS-CoV epidemic was conflicting. Interferons (α, β), however, demonstrated positive action against MERS-CoV [
 <xref rid="bib0035" ref-type="bibr">7</xref>,
 <xref rid="bib0130" ref-type="bibr">26</xref>]. Clinical data regarding this combination in the treatment of COVID-19 patients is still lacking, but several clinical trials are currently being conducted [
 <xref rid="bib0190" ref-type="bibr">38</xref>,
 <xref rid="bib0345" ref-type="bibr">69</xref>].
</p>
